Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations
Marshall, Catherine H., Sokolova, Alexandra O., McNatty, Andrea L., Cheng, Heather H., Eisenberger, Mario A., Bryce, Alan H., Schweizer, Michael T., Antonarakis, Emmanuel S.
Published in European urology (01.10.2019)
Published in European urology (01.10.2019)
Get full text
Journal Article
CDK12 -Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors
Antonarakis, Emmanuel S, Isaacsson Velho, Pedro, Fu, Wei, Wang, Hao, Agarwal, Neeraj, Sacristan Santos, Victor, Maughan, Benjamin L, Pili, Roberto, Adra, Nabil, Sternberg, Cora N, Vlachostergios, Panagiotis J, Tagawa, Scott T, Bryce, Alan H, McNatty, Andrea L, Reichert, Zachery R, Dreicer, Robert, Sartor, Oliver, Lotan, Tamara L, Hussain, Maha
Published in JCO precision oncology (01.11.2020)
Published in JCO precision oncology (01.11.2020)
Get more information
Journal Article
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
Velez, Miguel Gonzalez, Kosiorek, Heidi E, Egan, Jan B, McNatty, Andrea L, Riaz, Irbaz B, Hwang, Steven R, Stewart, Glenn A, Ho, Thai H, Moore, Cassandra N, Singh, Parminder, Sharpsten, Renee K, Costello, Brian A, Bryce, Alan H
Published in Prostate cancer and prostatic diseases (01.09.2022)
Published in Prostate cancer and prostatic diseases (01.09.2022)
Get full text
Journal Article
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer
Morgans, Alicia K., Shore, Neal, Cope, Diane, McNatty, Andrea, Moslehi, Javid, Gomella, Leonard, Sartor, Oliver
Published in Urologic oncology (01.01.2021)
Published in Urologic oncology (01.01.2021)
Get full text
Journal Article
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Hussain, Arif, Tripathi, Abhishek, Pieczonka, Christopher, Cope, Diane, McNatty, Andrea, Logothetis, Christopher, Guise, Theresa
Published in Prostate cancer and prostatic diseases (01.06.2021)
Published in Prostate cancer and prostatic diseases (01.06.2021)
Get full text
Journal Article
Response to PARP inhibitor therapy in metastatic castrate-resistant prostate cancer (mCRPC) patients with BRCA1/2 versus ATM mutations
Marshall, Catherine Handy, McNatty, Andrea, Eisenberger, Mario A., Bryce, Alan Haruo, Antonarakis, Emmanuel S.
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article